LSE - Delayed Quote USD

Elevance Health, Inc. (0HG8.L)

384.31
+1.95
+(0.51%)
At close: June 13 at 7:07:33 PM GMT+1

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Ms. Gail Koziara Boudreaux President, CEO & Director 3.67M -- 1961
Mr. Mark Bradley Kaye Executive VP & CFO 1.37M -- 1980
Mr. Peter David Haytaian Esq. Executive VP and President of Carelon & CarelonRx 1.55M 5M 1970
Mr. Charles Morgan Kendrick Jr. Executive VP & President of Commercial Health Benefits 1.49M -- 1966
Ms. Felicia Farr Norwood Executive VP & President of Government Health Benefits 1.49M 2.22M 1960
Mr. Scott Wayne Anglin SVP, Treasurer & Chief Investment Officer -- -- --
Mr. Ronald William Penczek Senior VP, Controller & Chief Accounting Officer -- -- 1965
Mr. Blair Williams Todt Executive VP and Chief Legal & Administrative Officer 2.11M 947.59k 1968
Mr. Nathan Allen Rich Vice President of Investor Relations -- -- --
Ms. Julie Goon Senior Vice President of Public Affairs -- -- --

Elevance Health, Inc.

220 Virginia Avenue
Indianapolis, IN 46204
United States
833 401 1577 https://www.elevancehealth.com
Full Time Employees: 
104,200

Description

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. It operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. The company offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. It also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, the company provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. It provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is headquartered in Indianapolis, Indiana.

Corporate Governance

Elevance Health, Inc.’s ISS Governance QualityScore as of June 1, 2025 is 2. The pillar scores are Audit: 2; Board: 1; Shareholder Rights: 6; Compensation: 3.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

July 15, 2025 at 12:30 PM UTC - July 21, 2025 at 12:30 PM UTC

Elevance Health, Inc. Earnings Date

Recent Events